SciClone Pharmaceuticals (Holdings) Limited

SEHK:6600 Stock Report

Mkt Cap: HK$6.7b

SciClone Pharmaceuticals (Holdings) Future Growth

How is SciClone Pharmaceuticals (Holdings) forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-1.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

SEHK:6600 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20243,4167914825682
12/31/20233,0859636108463
6/30/20222,6628331,2261,245N/A
3/31/20222,5908781,0321,137N/A
12/31/20212,5189238391,029N/A
9/30/20212,259837506840N/A
6/30/20212,089779358724N/A
3/31/20212,004766435853N/A
12/31/20201,919754512981N/A
9/30/20202,001817657974N/A
12/31/20191,7086159991,032N/A
12/31/20181,409535143167N/A
12/31/20171,21320143154N/A
6/30/20171,166294234242N/A
3/31/20171,146258183187N/A
12/31/20161,112213235240N/A
9/30/20161,060246215221N/A
6/30/20161,072257226231N/A
3/31/20161,034183N/A214N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6600's earnings are forecast to decline over the next 3 years (-1.3% per year).

Earnings vs Market: 6600's earnings are forecast to decline over the next 3 years (-1.3% per year).

High Growth Earnings: 6600's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 6600's revenue (9.8% per year) is forecast to grow faster than the Hong Kong market (9.6% per year).

High Growth Revenue: 6600's revenue (9.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 6600's Return on Equity is forecast to be high in 3 years time (23.6%)


Discover growth companies